Activation of the somatotropic axis by testosterone in adult males: Evidence for the role of aromatization

Journal of Clinical Endocrinology and Metabolism

Volumn 76, Issue 6, 1993, Pages 1407-1412

  Weissberger, Andrew J ^a   Ho, Ken K Y ^a  

^a ST VINCENT S HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL; GROWTH HORMONE; SOMATOMEDIN C; TAMOXIFEN; TESTOSTERONE; TESTOSTERONE ENANTATE;

ADULT; AROMATIZATION; ARTICLE; BODY GROWTH; CLINICAL ARTICLE; CONTROLLED STUDY; GROWTH HORMONE RELEASE; HORMONE BLOOD LEVEL; HORMONE SUBSTITUTION; HUMAN; HYPOGONADISM; INTRAMUSCULAR DRUG ADMINISTRATION; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL;

ADULT; GROWTH HORMONE; HUMAN; HYPOGONADISM; MALE; OSMOLAR CONCENTRATION; REFERENCE VALUES; SUPPORT, NON-U.S. GOV'T; TAMOXIFEN; TESTOSTERONE;

EID: 0027294807     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jcem.76.6.8501143     Document Type: Article

References (38)

1. Miller JD, Tannenbaum GS, Colle E, Guyda HJ. 1982 Daytime pulsatile growth hormone secretion during childhood and adolescence. J Clin Endocrinol Metab. 55: 989-994.
2. Mauras N, Blizzard RM, Link K, Johnson ML, Rogol AD, Veld-huis JD. 1987 Augmentation of growth hormone secretion during puberty: evidence for a pulse amplitude-modulated phenomenon. J Clin Endocrinol Metab. 64: 596-601.
3. Martha Jr PM, Rogol AD, Veldhuis JD, Kerrigan JR, Goodman DW, Blizzard RM. 1989 Alterations in the pulsatile properties of circulating growth hormone concentrations during puberty in boys. J Clin Endocrinol Metab. 69: 563-570.
4. Weissberger AJ, Ho KY, Lazarus L. 1989 Resolution of apparent growth-hormone dependent growth failure during puberty: A case report. Hormone Res. 32: 148-150.
5. Link K, Blizzard RM, Evans WS, Kaiser DL, Parker MW, Rogol AD. 1986 The effect of androgens on the pulsatile release and the twenty-four-hour mean concentration of growth hormone in peripubertal males. J Clin Endocrinol Metab. 62: 159-164.
6. Stanhope R, Pringle PJ, Brook CGD. 1988 The mechanism of the adolescent growth spurt induced by low dose pulsatile GnRH treatment. Clin Endocrinol. 28: 83-91.
7. Liu L, Merriam GR, Sherins RJ. 1987 Chronic sex steroid exposure increases mean plasma growth hormone concentration and pulse amplitude in men with isolated hypogonadotropic hypogonadism. J Clin Endocrinol Metab. 64: 651-656.
8. Giusti M, Torre R, Cavagnaro P, Attanasio R, Traverso L, Giordano G. 1989 The effect of long-term pulsatile GnRH administration on the 24-hour integrated concentration of GH in hypogonadotropic hypogonadic patients. Acta Endocrinol (Copenh). 120: 724-728.
9. Finkelstein JW, Roffwarg HP, Boyar RM, Kream J, Heilman L. 1972 Age-related change in the twenty-four-hour spontaneous secretion of growth hormone. J Clin Endocrinol Metab. 35: 665-670.
10. Bala RM, Lopatka J, Leung A, McCoy E, McCarthur RG. 1981 Serum immunoreactive somatomedin levels in normal adults, pregnant women at term, children at various ages, and children with constitutionally delayed puberty. J Clin Endocrinol Metab. 52: 508-512.
11. Luna AM, Wilson DM, Wibbelsman CJ, et al. 1983 Somatomedins in adolescence: A cross-sectional study of the effect of puberty on plasma insulin-like growth factor I and II levels. J Clin Endocrinol Metab. 57: 268-271.
12. Longcope C, Kato T, Horton R. 1969 Conversion of blood androgens to estrogens in normal adult men and women. J Clin Invest. 48: 2191-2201.
13. MacDonald PC, Madden JD, Brenner PF, Wilson JD, Siiteri PK. 1979 Origin of estrogen in normal men and in women with testicular feminization. J Clin Endocrinol Metab. 49: 905-916.
14. D'Agata R, Vicari E, Aliffi A, Gulizia S, Palumbo G. 1981 Direct evidence in men for a role of endogenous oestrogens on gonadotropin release. Acta Endocrinol (Copenh). 97: 145-149.
15. Finkelstein JS, Whitcomb RW, O'Dea L, Longcope C, Schoenfeld DA, Crowley WF. 1991 Sex steroid control of gonadotropin secretion in the human male: I. Effects of testosterone administration in normal and gonadotropin-releasing hormone deficient men. J Clin Endocrinol Metab. 73: 609-620.
16. Ho KY, Evans WS, Blizzard RM, et al. 1987 Effects of sex and age on the 24-hour profile of growth hormone secretion in man: importance of endogenous estradiol concentrations. J Clin Endocrinol Metab. 64: 51-58.
17. UUoa-Aguirre A, Blizzard RM, Garcia-Rubi E, et al. 1990 Testosterone and oxandrolone, a nonaromatizable androgen, specifically amplify the mass and rate of growth hormone (GH) secreted per burst without altering GH secretory burst duration or frequency or the GH half-life. J Clin Endocrinol Metab. 71: 846-54.
18. Vermeulen A, Comhaire F. 1978 Hormonal effects of an antiestrogen, tamoxifen, in normal and oligospermie men. Fertil Steril. 29: 320-327.
19. Buvat J, Ardaens K, Lemaire A, Gauthier A, Gasnault JP, Buvat-Herbaut M. 1983 Increased sperm count in 25 cases of idiopathic normogonadotropic oligospermia following treatment with tamoxifen. Fertil Steril. 39: 700-703.
20. Veldhuis JD, Johnson ML. 1986 Cluster analysis: A simple, versatile, and robust algorithm for endocrine pulse detection. Am J Physiol. 250: E486-493.
21. Weissberger AJ, Ho KKY, Lazarus L. 1991 Contrasting effects of oral and transdermal routes of estrogen replacement therapy on 24-hour growth hormone (GH) secretion, insulin-like growth factor I, and GH-binding protein in postmenopausal women. J Clin Endocrinol Metab. 72: 374-381.
22. Taylor AL, Finster JL, Mintz DH. 1969 Metabolic clearance and production rates of human growth hormone. J Clin Invest. 48: 2349-2358.
23. MacGillivray MH, Frohman LA, Doe J. 1970 Metabolic clearance and production rates of human growth hormone in subjects with normal and abnormal growth. J Clin Endocrinol Metab. 30: 632-638.
24. Rose SR, Ross JL, Uriarte M, Barnes KM, Cassorla FG, Cutler GB. 1988 The advantage of measuring stimulated as compared with spontaneous growth hormone levels in the diagnosis of growth hormone deficiency. N Engl J Med. 319: 201-207.
25. Bethea CL, Cronin MJ, Haluska GJ, Novy MJ. 1989 The effect of relaxin infusion on prolactin and growth hormone secretion in monkeys. J Clin Endocrinol Metab. 69: 956-962.
26. Bilezikjian LM, Corrigan AZ, Vale W. 1990 Activin-A modulates growth hormone secretion from cultures of rat anterior pituitary cells. Endocrinology. 126: 2369-2376.
27. Fox M, Minot AS, Liddle GW. 1962 Oxandrolone: A potent anabolic steroid of novel chemical configuration. J Clin Endocrinol Metab. 22: 921-924.
28. Lima L, Arce V, Lois N, et al. 1989 Growth hormone (GH) responsiveness to GHRH in normal adults is not affected by shortterm gonadal blockade. Acta Endocrinol (Copenh). 120: 31-36.
29. Tannenbaum GS, Gurd W, Lapointe M, Pollack M. 1992 Tamoxifen attenuates pulsatile growth hormone secretion: mediation in part by somatostatin. Endocrinology. 130: 3395-3401.
30. Metzger DL, Kerrigan JR. 1992 Augmentation of growth hormone (GH) secretion in late pubertal males following androgen receptor blockade. Prog 74th Meeting of the Endocrine Soc. 1081.
31. Jordan VC, Murphy CS. 1990 Endocrine pharmacology of antiestrogens as antitumour agents. Endocr Rev. 11: 578-610.
32. Santen RJ, Manni A, Harvey H, Redmond C. 1990 Endocrine treatment of breast cancer in women. Endocr Rev. 11: 221-265.
33. Sakai F, Cheix F, Clavel M, et al. 1978 Increases in steroid binding globulins induced by tamoxifen in patients with carcinoma of the breast. J Endocrinol. 76: 219-226.
34. Jordan VC, Fritz NF, Tormey DC. 1987 Long-term adjuvant therapy with tamoxifen: effects on sex hormone binding globulin and antithrombin III. Cancer Res. 47: 4517-4519.
35. von Schoultz B, Carlstrom K. 1989 On the regulation of sex-hormone-binding globulin: A challenge of an old dogma and outlines of an alternative mechanism. J Steroid Biochem. 32: 327-334.
36. Plymate SR, Hoop RC, Jones RE, Matej LA. 1990 Regulation of sex hormone-binding globulin production by growth factors. Metabolism. 39: 967-970.
37. Singh A, Hamilton-Fairley D, Koistinen R, et al. 1989 Effect of insulin-like growth factor-type I (IGF-I) and insulin on the secretion of sex hormone binding globulin and IGF-I binding protein (IBP-I) by human hepatoma cells. J Endocrinol. 121 (Abstract 246).
38. Poliak M, Constantino J, Polychronalas C, et al. 1990 Effects of tamoxifen on serum IGF-1 levels of stage 1 breast cancer patients. J Natl Cancer Inst. 82: 1693-1697.